XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Beginning balance (shares) at Dec. 31, 2021   3,171,536    
Beginning Balance at Dec. 31, 2021 $ 184,422,902 $ 80,434,049 $ (15,268,705) $ 119,257,558
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   75,764    
Issuance of restricted stock grants   $ 13,366,316 (13,366,316)  
Amortization of restricted stock grants 5,140,104   5,140,104  
Issuance of stock grants (in shares)   2,743    
Issuance of stock grants 487,870 $ 487,870    
Issuance of common stock related to 401k plan match (in shares)   211    
Issuance of common stock related to 401k plan match 37,313 $ 37,313    
Issuance of common stock related to employee stock purchase plan (in shares)   2,692    
Issuance of common stock related to employee stock purchase plan 499,335 $ 499,335    
Shares withheld related to employee tax withholding (in shares)   (9,511)    
Shares withheld related to employee tax withholding (1,781,410) $ (1,781,410)    
Forfeiture of restricted stock grants (shares)   (1,321)    
Forfeiture of restricted stock grants   $ (244,509) 244,509  
Repurchase of common stock (shares)   (119,797)    
Repurchase of common stock (21,699,248) $ (21,699,248)    
Cash dividends paid (9,528,917)     (9,528,917)
Net income 13,542,838     13,542,838
Ending balance (shares) at Jun. 30, 2022   3,122,317    
Ending Balance at Jun. 30, 2022 171,120,787 $ 71,099,716 (23,250,408) 123,271,479
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2021 17,756,336      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest 4,052,058      
Net subscriptions of consolidated funds 8,595,911      
Ending balance attributable to redeemable noncontrolling Interests at Jun. 30, 2022 22,300,189      
Beginning balance (shares) at Mar. 31, 2022   3,191,487    
Beginning Balance at Mar. 31, 2022 182,610,019 $ 83,517,125 (24,476,298) 123,569,192
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   9,574    
Issuance of restricted stock grants   $ 1,665,535 (1,665,535)  
Amortization of restricted stock grants 2,891,425   2,891,425  
Issuance of common stock related to 401k plan match (in shares)   103    
Issuance of common stock related to 401k plan match 18,064 $ 18,064    
Issuance of common stock related to employee stock purchase plan (in shares)   357    
Issuance of common stock related to employee stock purchase plan 61,989 $ 61,989    
Shares withheld related to employee tax withholding (in shares)   (9,511)    
Shares withheld related to employee tax withholding (1,781,410) $ (1,781,410)    
Repurchase of common stock (shares)   (69,693)    
Repurchase of common stock (12,381,587) $ (12,381,587)    
Cash dividends paid (4,710,599)     (4,710,599)
Net income 4,412,886     4,412,886
Ending balance (shares) at Jun. 30, 2022   3,122,317    
Ending Balance at Jun. 30, 2022 171,120,787 $ 71,099,716 (23,250,408) 123,271,479
Beginning balance attributable to redeemable noncontrolling Interests at Mar. 31, 2022 20,738,520      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest 3,197,122      
Net subscriptions of consolidated funds 4,758,791      
Ending balance attributable to redeemable noncontrolling Interests at Jun. 30, 2022 $ 22,300,189      
Beginning balance (shares) at Dec. 31, 2022 3,010,457 3,010,457    
Beginning Balance at Dec. 31, 2022 $ 163,672,245 $ 51,688,631 (17,011,144) 128,994,758
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   55,684    
Issuance of restricted stock grants   $ 10,481,741 (10,481,741)  
Amortization of restricted stock grants 5,839,740   5,839,740  
Issuance of stock grants (in shares)   0    
Issuance of stock grants 0 $ 0    
Issuance of common stock related to 401k plan match (in shares)   99    
Issuance of common stock related to 401k plan match 16,344 $ 16,344    
Issuance of common stock related to employee stock purchase plan (in shares)   2,378    
Issuance of common stock related to employee stock purchase plan 394,159 $ 394,159    
Shares withheld related to employee tax withholding (in shares)   (24,600)    
Shares withheld related to employee tax withholding (4,173,781) $ (4,173,781)    
Forfeiture of restricted stock grants (shares)   (3,464)    
Forfeiture of restricted stock grants   $ (565,519) 565,519  
Repurchase of common stock (shares)   (90,290)    
Repurchase of common stock (14,938,025) $ (14,938,025)    
Cash dividends paid (9,009,648)     (9,009,648)
Net income $ 22,140,031     22,140,031
Ending balance (shares) at Jun. 30, 2023 2,950,264 2,950,264    
Ending Balance at Jun. 30, 2023 $ 163,941,065 $ 42,903,550 (21,087,626) 142,125,141
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2022 14,126,198      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest (2,131,965)      
Net subscriptions of consolidated funds 6,485,835      
Ending balance attributable to redeemable noncontrolling Interests at Jun. 30, 2023 22,743,998      
Beginning balance (shares) at Mar. 31, 2023   3,027,738    
Beginning Balance at Mar. 31, 2023 169,247,354 $ 55,690,092 (23,568,556) 137,125,818
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   6,585    
Issuance of restricted stock grants   $ 1,080,755 (1,080,755)  
Amortization of restricted stock grants 2,996,166   2,996,166  
Issuance of common stock related to 401k plan match (in shares)   53    
Issuance of common stock related to 401k plan match 8,501 $ 8,501    
Issuance of common stock related to employee stock purchase plan (in shares)   415    
Issuance of common stock related to employee stock purchase plan 71,089 $ 71,089    
Shares withheld related to employee tax withholding (in shares)   (18,479)    
Shares withheld related to employee tax withholding (3,041,274) $ (3,041,274)    
Forfeiture of restricted stock grants (shares)   (3,464)    
Forfeiture of restricted stock grants   $ (565,519) 565,519  
Repurchase of common stock (shares)   (62,584)    
Repurchase of common stock (10,340,094) $ (10,340,094)    
Cash dividends paid (4,433,156)     (4,433,156)
Net income $ 9,432,479     9,432,479
Ending balance (shares) at Jun. 30, 2023 2,950,264 2,950,264    
Ending Balance at Jun. 30, 2023 $ 163,941,065 $ 42,903,550 $ (21,087,626) $ 142,125,141
Beginning balance attributable to redeemable noncontrolling Interests at Mar. 31, 2023 17,332,798      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest (736,470)      
Net subscriptions of consolidated funds 4,674,730      
Ending balance attributable to redeemable noncontrolling Interests at Jun. 30, 2023 $ 22,743,998